List of all Challenge substances This table represents the composition status of the substances in each batch as of the 26 December 2009 launch of Batch 12. The composition of each Challenge batch is confirmed 3 months before it is launched in the Canada Gazette Part 1. Substance Name Challenge Categorization Batch no. Decision Finalized Challenge Batches (as of the 26 December 2009 Launch of Batch 12)
(1,1,4,4-tetramethyl-1,4-butanediyl)bis[(1,1- Batch 1
(3,3,5-trimethylcyclohexylidene)bis[(1,1-
(acetylamino)phenyl]-4-[[5-(aminocarbonyl)-2-chlorophenyl]azo]-3-hydroxy-
methoxyphenyl)amino]carbonyl]-1-naphthalenyl]azo]-4-methylbenzoyl]amino]-, calcium salt (2:1)
cyclohexylphenoxy)ethyl]ethylamino]-2-methylphenyl]methylene]-
(aminocarbonyl)phenyl]amino]carbonyl]-2-methoxyphenyl]azo]-N-( 5-chloro-2,4-dimethoxyphenyl)-3-hydroxy-
1,3-bis(1-isocyanato-1-methylethyl)- Batch
1,4-anthracenediyl)diimino]bis[2,4,6-trimethyl-, disodium salt
15086-94-9 Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one,
anthracenediyl)bis(imino-4,1-phenyleneoxy)]bis-, disodium salt
Benzenesulfonic acid, 2,2 -[(9,10-dihydro-5,8-
dihydroxy-9,10-dioxo-1,4-anthracenediyl)diimino]bis[5-(1,1-dimethylethyl)-, disodium salt
methylphenyl)amino]-, sulfonated, potassium salts
methoxy-9,10-dioxo-1-anthracenyl)-4-methyl-
2-Naphthalenol, 1-[(4-methyl-2-nitrophenyl)azo]-
2-Naphthalenol, 1-[(2-chloro-4-nitrophenyl)azo]-
2-Naphthalenol, 1-[(2,4-dinitrophenyl)azo]-
2-Naphthalenol, 1-[(4-chloro-2-nitrophenyl)azo]-
dimethoxyphenyl)-4-[[5-[(diethylamino)sulfonyl]-2-methoxyphenyl]azo]-3-hydroxy-
methylethylidene)bis(4,1-phenyleneimino)]bis[1-amino-9,10-dihydro-9,10-dioxo-, disodium salt
methylethylidene)]bis[(1,1-dimethylethyl)
3-[[4-[(2,4-dimethylphenyl)amino]- Batch 3
9,10-dihydro-9,10-dioxo-1-anthracenyl]amino]-N,N,N-trimethyl-, methylsulfate
dioxo-3-[sulfo-4-(1,1,3,3-tetramethylbutyl)phenoxy]-1-anthracenyl]amino]-2,4,6-trimethyl-, disodium salt
methyl-9-oxopyrazolo[5,1-b]quinazolin-3-yl)azo]-
Phenol, 4,4 -(3H-2,1-benzoxathiol-3-ylidene)bis[2,6-
Phenol, 4,4 -(3H-2,1-benzoxathiol-3-ylidene)bis[2-
Phenol, 4,4 -(3H -2,1-benzoxathiol-3-ylidene)bis[2,5-
2-[(3,5-dibromo-4-hydroxyphenyl)(3,5- Batch 4
dibromo-4-oxo-2,5-cyclohexadien-1-ylidene)methyl]-, ethyl ester
17321-77-6 5H-Dibenz[b,f]azepine-5-propanamine, 3-chloro-
10,11-dihydro-N,N-dimethyl-, monohydrochloride
Phenol, 4,4 -(3H-1,2-benzoxathiol-3-ylidene)bis[2,6-
dibromo-3-methyl-, S,S-dioxide, monosodium salt
Amines, tallow alkyl, ethoxylated, phosphates
Benzenamine, N-phenyl-, reaction products with
dimethyl-7-(1-methylethyl)-1-phenanthrenyl]methyl](3-oxo-3-phenylpropyl)amino]-, [1R-(1a,4aß,10aa)]-
dichloro-4-nitrophenyl)azo]phenyl]amino]-
[(2-bromo-4,6-dinitrophenyl)azo]-4-ethoxyphenyl]-
(acetyloxy)ethyl](phenylmethyl)amino]-2-[(2-chloro-4,6-dinitrophenyl)azo]-4-methoxyphenyl]-
(acetyloxy)ethyl](phenylmethyl)amino]-2-[(2,4-dinitrophenyl)azo]-4-methoxyphenyl]-
nitrophenyl)azo]-3-chlorophenyl]imino]bis-
N-[5-[bis[2-(acetyloxy)ethyl]amino]-2- Batch 5
N-[2-[(2-bromo-4,6-dinitrophenyl)azo]-5- Batch 5
nitrophenyl)azo]phenyl]imino]bis-, diacetate (ester)
4-[(2,6-dichloro-4-nitrophenyl)azo]-N- Batch 5
2-Naphthalenol, 1-[[4-(phenylazo)phenyl]azo]-
2-Naphthalenol, 1-[(2-methoxyphenyl)azo]-
2,7-Naphthalenedisulfonic acid, 4-amino-3-[[4'-[(2,4-
diaminophenyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-6-(phenylazo)-, disodium salt
2-Naphthalenol, 1-[(2,4-dimethylphenyl)azo]-
Phenol, 4-[[4-(phenylazo)-1-naphthalenyl]azo]-
Phenol, 2-methyl-4-[[4-(phenylazo)phenyl]azo]-
2,7-Naphthalenedisulfonic acid, 3-[[2,2'-dimethyl-4'-
[[4-[[(4-methylphenyl)sulfonyl]oxy]phenyl]azo][1,1'-biphenyl]-4-yl]azo]-4-hydroxy-, disodium salt
1-Naphthalenol, 4-[(4-ethoxyphenyl)azo]-
2,2'-[(3,3'-dimethoxy[1,1'-biphenyl]-4,4'- Batch 6
diyl)bis(azo)]bis[N-(2-methylphenyl)-3-oxo-
Phenol, 4,4'-[1,4-phenylenebis(azo)]bis-
4-[[2-methoxy-4-[(2-methoxyphenyl)azo]-5-
1,2-Benzenedicarboxylic acid, bis(2-methoxyethyl)
1,2-Benzenedicarboxylic acid, di-C7-11-branched and Batch 6
29398-96-7* [1,1'-Biphenyl]-4,4'-diamine,
methylphenyl)azo]-5-(dipropylamino)phenyl]-
Benzoic acid, 2,3,4,5-tetrachloro-6-cyano-, methyl
ester, reaction products with 4-[(4-aminophenyl)azo]-3-methylbenzenamine and sodium methoxide
1,2,3,4-tetrachloro-5,6-dimethoxy- Batch
hydroxyphenyl]methyl]-, monoethyl ester, calcium salt (2:1)
hydroxy-, (1,2-dioxo-1,2-ethanediyl)bis(imino-2,1-ethanediyl) ester
Phosphonium, triphenyl(phenylmethyl)-, salt with 4,4 - Batch 8
[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]bis[phenol] (1:1)
475-71-8* Benzo[h]benz[5,6]acridino[2,1,9,8-klmna]acridine-
509-34-2 Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one,
1326-05-2 Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one,
2',4',5',7'-tetrabromo-3',6'-dihydroxy-, lead salt
tetrabromo-6-hydroxy-3-oxo-3H-xanthen-9-yl)-
methyl-3-oxobenzo[b]thien-2(3H)-ylidene)-4-methyl-
Oxirane, 2,2' ,2'' ,2''' -[1,2-ethanediylidenetetrakis(4,1- Batch 9
dichloro-3-oxobenzo[b]thien-2(3H)-ylidene)-
bis[1-[4-(dimethylamino)phenyl]-2-phenyl-
dichlorophenyl)amino]carbonyl]-3,3-dimethyl-2-oxobutoxy]-
64338-16-5 7-Oxa-3,20-diazadispiro[5.1.11.2]heneicosan-21-one, Batch 9
2-Naphthalenesulfonic acid, 7-[[4,6-bis[[3-
(diethylamino)propyl]amino]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[[4-(phenylazo)phenyl]azo]-, monoacetate (salt)
Resin acids and Rosin acids, hydrogenated, esters with Batch 10
Resin acids and Rosin acids, hydrogenated, esters with Batch 10
Resin acids and Rosin acids, hydrogenated, esters with Batch 10
185702-90-5 2,9,11,13-Tetraazanonadecanethioic acid, 19-
isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-, S-[3-(trimethoxysilyl)propyl] ester
Resin acids and Rosin acids, fumarated, barium salts
N'-(3,4-dichlorophenyl)-N,N-dimethyl- Batch
1,1'-(chlorophenylmethylene)bis[4-methoxy- Batch
2-Propanone, reaction products with diphenylamine
1,4-Benzenediamine, N,N'-mixed tolyl and xylyl
Siloxanes and Silicones, Me 3,3,3-trifluoropropyl, Me Batch 11
1,4-Benzenediamine, N,N'-mixed Ph and tolyl derivs. Batch 11
Silicones, di-Me, reaction products with Batch 11
Me hydrogen siloxanes and 1,1,3,3-tetramethyldisiloxane
Siloxanes and Silicones, di-Me, hydrogen-terminated
products with hexakis(methoxymethyl)melamine
Hexanedioic acid, bis(2-ethylhexyl) ester
56-95-1 2,4,11,13-Tetraazatetradecanediimidamide, N,N' -
bis(4-chlorophenyl)-3,12-diimino-, diacetate
Naphthalenepropanol, *-ethenyldecahydro-2-
hydroxy-*,2,5,5,8a-pentamethyl-, [1R-[1a(R*),2ß,4aß,8a*]]-
Benzenamine, 4,4’ -[(1-methylethylidene)bis(4,1-
nitrophenyl)azo]phenyl]-N-(3-methoxy-3-oxopropyl)-, methyl ester
Ethanamine, N-ethyl-N-hydroxy-, reaction products
with hexamethylcyclotrisiloxane, silica and 1,1,1-trimethyl-N -(trimethylsilyl)silanamine
Silanamine, 1,1,1-trimethyl- N-(trimethylsilyl)-,
reaction products with ammonia, octamethylcyclotetrasiloxane and silica
* Substances for which no response was received to the notice published in the Canada Gazette, Part I,
Vol. 140, No. 9, under section 71 of the Canadian Environmental Protection Act, 1999, on March 4, 2006, but for which stakeholders submitted the Declaration of Non-Engagement form indicating their interest in the substances.
** Substances added to the Challenge as a result of information received during public comments on the
December 9, 2006 Notice with respect to the draft screening assessment report on 148 PBiT substances published in the Canada Gazette, Part I, along with a notice of intent to amend the Domestic Substances List to apply the Significant New Activity provisions under subsection 81(3) of the Canadian Environmental Protection Act, 1999 to these 148 substances.
A PERSONAL JOURNEY of PAIN, STRESS and CHRONIC FATIGUE The term fibromyalgia was first thought to be psychological because there was not much research being done on the many symptoms that patients were experiencing. Some Dr.’s even thought that the pain was being caused by depression and treated their patients only with antidepressants that did not take away the pain. Thankfully, it is now
MRSA Fact Sheet 1. What is Staphylococcus aureus ? - Staphylococcus aureus , often referred to simply as "staph," are bacteria commonly carried on the skin or in the nose of healthy people. Approximately 25% to 30% of the population is colonized (when bacteria are present, but not causing an infection) in the nose with staph bacteria. Sometimes, staph can also cause an infe